<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0525">
 <label>105</label>
 <element-citation publication-type="journal" id="rf0515">
  <person-group person-group-type="author">
   <name>
    <surname>Pu</surname>
    <given-names>S.-Y.</given-names>
   </name>
   <name>
    <surname>Xiao</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Schor</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Bekerman</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Zanini</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Barouch-Bentov</surname>
    <given-names>R.</given-names>
   </name>
  </person-group>
  <article-title>Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment</article-title>
  <source>Antiviral Res</source>
  <volume>155</volume>
  <year>2018</year>
  <fpage>67</fpage>
  <lpage>75</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2018.05.001</pub-id>
  <pub-id pub-id-type="pmid">29753658</pub-id>
 </element-citation>
</ref>
